DexCom/ US2521311074 /
| 10/2/2023 4:11:05 PM | Chg. +0.57 | Volume | Bid4:11:23 PM | Ask4:11:23 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 93.89USD | +0.61% | 15,797 Turnover: 1.47 mill. |
92.78Bid Size: 136 | 101.41Ask Size: 100 | 35.99 bill.USD | - | 105.44 |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.88 USD | 120.00% |
| EPS Diluted: | 0.82 USD | 111.61% |
| Revenues per Share: | 7.53 USD | 19.41% |
| Book Value per Share: | 5.52 USD | -4.86% |
| Cash Flow per Share: | 1.73 USD | 52.02% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 2,909.80 USD | 18.84% |
| Net Income: | 341.20 USD | 120.56% |
| Operating Cash Flow: | 669.50 USD | - |
| Cash and Cash Equivalents: | 642.30 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 105.44 | 128.68 |
| P/S Ratio: | 12.32 | 15.04 |
| P/BV ratio: | 16.82 | 20.53 |
| P/CF Ratio: | 53.56 | 65.36 |
| PEG: | 0.88 | 1.07 |
| Earnings Yield: | 0.95% | 0.78% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 35.99 bill. USD | 43.76 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 387.87 mill. | |
Profitability
| Gross Profit Margin: | 64.72% |
| EBIT Margin: | 13.44% |
| Net Profit Margin: | 11.73% |
| Return on Equity: | 16.01% |
| Return on Assets: | 6.33% |
Financial Strength
| Liquidity I / Cash Ratio: | 34.92% |
| Liquidity II / Quick Ratio: | 73.70% |
| Liquidity III / Current Ratio: | 199.47% |
| Debt / Equity Ratio: | 152.92% |
| Dynam. Debt / Equity Ratio: | 486.92% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2022 |
| Accounting Standard: | US GAAP |
| Currency: | USD |